Brook K. Baker in the Press
This pharma company makes a miracle HIV drug, but is blocking access for millions of low-income people
Although Gilead has applied for or received patents for lenacapavir in 15 of the excluded countries, “it has made no promises that it will sell or license the drug in those countries,” says Brook Baker of Northeastern University Law School, who has followed the licensing issue closely.
Al Jazeera
In a historic move, Colombia bypasses patent to access HIV drug
Colombia is “a shining example of a country that has taken a little bit of risk”, said Brook Baker, a health policy analyst and law professor emeritus at Northeastern University.
South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
Now, poorer countries are trying to become more self-reliant “because they’ve realized after COVID they can’t count on anyone else,” said Brook Baker, who studies treatment-access issues at Northeastern University.
Abortion Pill, Vaccine Attacks Spell Trouble for FDA Approvals
When it comes to distrust in FDA processes, it’s the agency’s activity during the US AIDS movement “that’s come back to haunt us a little bit,” said Brook Baker, a Northeastern University law professor.
The Chronicle of Philanthropy
Gates Foundation to Increase Funding to $8.3 Billion This Year
The power the Seattle grant maker has over global health organizations concerns Brook Baker, a law professor at Northeastern University School of Law and senior analyst for the Health Global Access Project, an international advocacy organization that pushes to make HIV treatments available.
Bloomberg Law
Biden’s Omicron Booster Campaign Faces Fatigue, Efficacy Doubts
“We are working against the tide of Covid fatigue, misinformation, and the government’s broken promises that the end is right around the corner,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on equity in access to HIV medications.
Bloomberg Law
Moderna Patent Strike on Pfizer Sets Up Post-Covid Vaccine Feuds
“Pfizer has know-how but should be rightly concerned about blocking patents on mRNA platform technologies,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP.
ABC News
WHO to share vaccines to stop monkeypox amid inequity fears
“Just like with COVID, there is no clear path for how poorer countries will be able to get vaccines,” Brook Baker, a Northeastern University law professor who specializes in access to medicines, said.
As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis
“Both Merck and Pfizer have reserved for themselves all the high-income countries and virtually all of the upper-middle-income countries and even some lower-middle-income countries,” said Brook Baker, a law professor at Northeastern University who has submitted a legal brief in support of the Dominican Republic petition.
Covid Booster Costs Spur Calls to Shift From Free Jabs for All (1)
“The provision of vaccines on a long-term basis is probably going to devolve back to our fractured private and public sectors, instead of being paid for exclusively by the federal government,” said Brook Baker, a professor at Northeastern University School of Law and a senior policy analyst at Health GAP, an advocacy group focusing on […]
